2021 Webinars

Opening the policy black box: Unravelling the process for changing diagnostic and treatment guidelines for vivax malaria in seven countries and Options Assessment Toolkit: Assisting Asia Pacific National Malaria Programs for Optimized Radical Cure of Vivax Malaria

Ms Varunika Ruwanpura, PhD Candidate, Public Health, Menzies School of Heath Research, Charles Darwin University Australia
Dr Manash ShresthaTechnical Coordinator, APMEN Vivax Working Group


PAVE: Implementation research needs between pipeline and policy

Dr Caroline Lynch, Medicines for Malaria Venture; co-chair of the APMEN Vivax Working Group




Understanding the factors underlying malaria resurgence in East Sepik, Papua New Guinea: a preliminary analysis

Dr Shazia Ruybal-Pesántez, Postdoctoral Scientist, Walter and Eliza Hall Institute and Burnet Institute




Optimising primaquine treatment regimens for paediatric vivax malaria

Dr Brioni Moore, Curtin Medical School




Biomarker based diagnosis of severe malaria in African children

Dr James Watson, Statistician, Mahidol Oxford Tropical Medicine Research Unit




Retargeting azithromycin as an antimalarial with dual mechanisms of action

Dr Danny Wilson, University of Adelaide





G6PD activity in individuals with and without malaria

Dr Benedikt Ley, Senior Research Fellow, Menzies School of Health Research




The role of Kelch 13 protein in the malaria parasite Plasmodium falciparum

Ms Madel Tutor, Cellular and Molecular Biologist





Super-resolution fluroescence imaging of rhoptries reveals essential role for PfCERLI1 in Plasmodium falciparum merozoite invasion of erythrocytes

Dr Sonja Frolich,




Malaria parasite trafficking defect: weird knobs, vesicle pile-up and failure to deliver a virulence factor

Ms Olivia Carmo, PhD Candidate, University of Melbourne